Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 18, 2013

Primary Completion Date

March 21, 2018

Study Completion Date

September 5, 2018

Conditions
Spinal Cord Contusion
Interventions
BIOLOGICAL

Human Allogeneic Umbilical Cord Blood Mononuclear Cells (hUCBMCs) systemic (i.v.) infusions

"HUCBMCs samples were prepared for infusion in the specialized laboratory of Cord Blood Bank (CryoCenter Ltd) and transported to the clinic immediately within 2 hours in the Dry Shipper. All samples were chosen according to patients blood group and rhesus-factor.~All samples were examined for hemotransmissive infections and cell viability prior to the preparation.~Obtained samples were infused through the blood transfusion systems with additional filter after 3 tests for biological and individual compatibility and tolerance.~Each patient of the pilot group received 4 cell infusions (1 infusion per week) with 1 week interval during the in-hospital treatment."

Trial Locations (1)

129090

N.V. Sklifosovsky Emergency Care Institute, Moscow

All Listed Sponsors
collaborator

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

OTHER_GOV

lead

Sklifosovsky Institute of Emergency Care

OTHER_GOV

NCT04331405 - Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury | Biotech Hunter | Biotech Hunter